Upsher-Smith sells AmLactin to Sandoz
MAPLE GROVE, Minn. — Upsher-Smith Laboratories Inc. has entered an agreement to sell its AmLactin skin care brand to Sandoz Inc. Financial terms of the deal weren’t disclosed. Upsher-Smith said the move is part of its strategy of focusing on generic drugs and novel therapies. AmLactin is formulated to gently exfoliate and relieve dryness associated